1. A Novel Tanshinone Analog Exerts Anti-Cancer Effects in Prostate Cancer by Inducing Cell Apoptosis, Arresting Cell Cycle at G2 Phase and Blocking Metastatic Ability
   Mengling Wang et al, 2019, International Journal of Molecular Sciences CrossRef
2. FCHO1560−571 peptide, a PKB kinase motif, inhibits tumor progression
   Sungjin Park et al, 2020, Biochemical and Biophysical Research Communications CrossRef
3. Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment
   Yoshiro Itatani et al, 2019, International Journal of Molecular Sciences CrossRef
4. Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine
   Ryia Illani Mohd Yunos et al, 2020, Biomolecules CrossRef
5. Mir-675-5p supports hypoxia-induced drug resistance in colorectal cancer cells
   Chiara Zichittella et al, 2022, BMC Cancer CrossRef
6. Long non‐coding RNA SNHG16 decreased SMAD4 to induce gemcitabine resistance in pancreatic cancer via EZH2‐mediated epigenetic modification
   Yi Yu et al, 2022, The Kaohsiung Journal of Medical Sciences CrossRef
7. Long noncoding RNA lncARSR confers resistance to Adriamycin and promotes osteosarcoma progression
   Peng Shen et al, 2020, Cell Death & Disease CrossRef
8. TILRR Aggravates Sepsis-Induced Acute Lung Injury by Suppressing the PI3K/Akt Pathway
   Xiaoyu Wang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
9. 18 β-glycyrrhetinic acid exhibits potent antitumor effects against colorectal cancer via inhibition of cell proliferation and migration
   Saisai Wang et al, 2017, International Journal of Oncology CrossRef
10. 5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
    Sabrina Blondy et al, 2020, Cancer Science CrossRef
11. Molecular mechanism of α-Hederin in tumor progression
    Dandan Meng et al, 2024, Biomedicine & Pharmacotherapy CrossRef
12. Down-Regulation of MicroRNA-210 Confers Sensitivity towards 1’S-1’-Acetoxychavicol Acetate (ACA) in Cervical Cancer Cells by Targeting SMAD4
    Neoh Hun Phuah et al, 2017, Molecules and Cells CrossRef
13. Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis
    Tian Fang et al, 2021, BMC Gastroenterology CrossRef
14. Knockdown of PARP6 or survivin promotes cell apoptosis and inhibits cell invasion of colorectal adenocarcinoma cells
    Haipeng Wang et al, 2017, Oncology Reports CrossRef
15. Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks
    Sepideh Mirzaei et al, 2023, Pathology - Research and Practice CrossRef
16. Metformin increases the cytotoxicity of oxaliplatin in human DLD‐1 colorectal cancer cells through down‐regulating HMGB1 expression
    Wen‐Shih Huang et al, 2018, Journal of Cellular Biochemistry CrossRef
17. Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial‑mesenchymal transition
    Zhenlv Lin et al, 2019, Molecular Medicine Reports CrossRef
18. Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products via the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications
    Indy Bui et al, 2023, Antioxidants & Redox Signaling CrossRef
19. Smad4 re-expression increases the sensitivity to parthenolide in colorectal cancer
    Xuemei Li et al, 2017, Oncology Reports CrossRef
20. Synthesis and antitumor activity of fluorouracil – oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates
    Chun-Mei Liu et al, 2019, MedChemComm CrossRef
21. Assessment of the Influence of 5-Fluorouracil on SMAD4 and TGFB1 Gene Expression, Apoptosis Induction and DNA Damage in Human Cell Lines
    Agnieszka Wosiak et al, 2023, Bioengineering CrossRef